Cargando…
P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431100/ http://dx.doi.org/10.1097/01.HS9.0000971544.34732.2d |
| _version_ | 1785091119750578176 |
|---|---|
| author | Zou, Hesong Liu, Wei Shan, Dandan Liu, Huimin Xie, Ting Huang, Wenyang Wang, Yi Yi, Shuhua Xu, Yan An, Gang Sui, Weiwei Wang, Tingyu Qiu, Lugui Zou, Dehui |
| author_facet | Zou, Hesong Liu, Wei Shan, Dandan Liu, Huimin Xie, Ting Huang, Wenyang Wang, Yi Yi, Shuhua Xu, Yan An, Gang Sui, Weiwei Wang, Tingyu Qiu, Lugui Zou, Dehui |
| author_sort | Zou, Hesong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431100 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311002023-08-17 P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA Zou, Hesong Liu, Wei Shan, Dandan Liu, Huimin Xie, Ting Huang, Wenyang Wang, Yi Yi, Shuhua Xu, Yan An, Gang Sui, Weiwei Wang, Tingyu Qiu, Lugui Zou, Dehui Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431100/ http://dx.doi.org/10.1097/01.HS9.0000971544.34732.2d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zou, Hesong Liu, Wei Shan, Dandan Liu, Huimin Xie, Ting Huang, Wenyang Wang, Yi Yi, Shuhua Xu, Yan An, Gang Sui, Weiwei Wang, Tingyu Qiu, Lugui Zou, Dehui P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA |
| title | P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA |
| title_full | P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA |
| title_fullStr | P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA |
| title_full_unstemmed | P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA |
| title_short | P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA |
| title_sort | p1162: front-line risk-adapted therapy presented favorable outcomes for young patients with diffuse large b-cell lymphoma: results from a consecutive cohort in china |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431100/ http://dx.doi.org/10.1097/01.HS9.0000971544.34732.2d |
| work_keys_str_mv | AT zouhesong p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT liuwei p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT shandandan p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT liuhuimin p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT xieting p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT huangwenyang p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT wangyi p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT yishuhua p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT xuyan p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT angang p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT suiweiwei p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT wangtingyu p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT qiulugui p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina AT zoudehui p1162frontlineriskadaptedtherapypresentedfavorableoutcomesforyoungpatientswithdiffuselargebcelllymphomaresultsfromaconsecutivecohortinchina |